References
- O'Reilly R.J. Allogeneic bone marrow transplantation: current status and future directions. Blood 1982; 62: 941–964
- Bone marrow and organ transplantation: Achievements and Goals, S. Slavin. Elsevier, Amsterdam 1984
- Slavin S., Nagler A. New developments in bone marrow transplantation. Current Opinion in Oncology 1991; 33: 254–271
- Ferrara J. L. M., Deeg H. J. D. Graft versus host disease. New Engl. J. Med. 1991; 324: 667–674
- DeGast G.C., Gratama J.W., Ringden O., Gluckman E. The multifactorial etiology of graft versus host disease. Immunol. Today 1987; 8: 209–212
- Jadus M.R., Wepsic H.J. The role of cytokines in graft-versus-host reactions and disease. Bone Marrow Transplantation 1992; 10: 1–14
- Weinberg K., Lawrence K., Barrantos B., Lenarsky C., Parkman R. The role of cytokines in the pathogenesis of human graft versus host disease. Exper. Hematol. 1992; 20: 717, (Abstract)
- Smith S.R., Terminelli C., Kenworthy-Bott L., Phillips D.L. A study of cytokine production in acute GVHD. Cell Immunol. 1991; 134: 336–348
- Knulst A.C. Cytokines in lethal GVHD. Transplant Int. 1992; 5: 5679–5683
- Ferrara J. L. M. Advances in GVHD: Novel lymphocyte subsets and cytokine dysregulation. BM Transplant 1992; 10(Suppl. 1)10–14
- Amtin J.H., Ferrara J. L. M. Cytokine dysregulation and acute graft versus-host disease. Blood 1992; 80: 2964–2968
- Parkman R., Lenarsky C., Santos R., Barrantes B., Weinberg K. Cytokines during acute graft versus host disease (GVHD) following matched unrelated donor (MUD) transplantation. Blood 1991; 78: 286a, (Abstr.)
- Tong J., Viale M., Bacigalupoe A., Podesta M., Sogno G., Tedone E., Marmont A.M. Cytokine serum levels and acute graft versus host disease after allogeneic bone marrow transplantation. Hematologica 1992; 77: 365–366
- Jadus M.R., Wepsic H.T. The role of cytokines in graft versus host reactions and disease. Bone Marrow Transplantation 1992; 10: 1–14
- Fuji Y., Koku K., Kaneko T. TNF is associated with chronic GVHD in BMT recipients. Bone Marrow Transplantation 1992; 10: 194–195
- Holler E., Kolb H.J., Moller A., Kempeni J., et al. Increased serum levels of tumor necrosis factor precede major complications of bone marrow transplantation. Blood 1990; 75: 1011–1016
- McCarthy P.L., Abhyanhan S., Neben S., et al. Inhibition of Interleukin-1 by an Interleukin-1 receptor antagonist prevents Graft-Versus Host Disease. Blood 1991; 78: 1915–1918
- Symington F.W., Symington B.E., Liu P.Y., Viguet H., Santhanam U., Sengal P.B. The relationship of serum IL-6 levels to acute graft versus host disease and hepatorenal disease after human bone marrow transplantation. Transplantation 1992; 54: 4557–4562
- Kanamara A., Hara H. Hematopoietic factors in graft versus host reaction. Intematl. J. Cell Cloning 1987; 5: 450–462
- Reyes V.E., Klimpel G.R. Interferon alpha/beta synthesis during acute graft versus host disease. Transplantation 1987; 43: 412–416
- Barrett A.J. Graft versus host disease—clinical features and biology. Bone Marrow Transplantation 1989; 4: 18–22
- Bianco J.A., Appelbaum F.R., Nemunaitis J., et al. Phase I-II trial of pentoxifylline for the prevention of transplanted-related toxicities following bone marrow transplantation. Blood 1991; 79: 1205–1211
- Herve P., Flesch M., Tiberghien P., et al. Phase III trial of a monoclonal anti TNF alpha antibody (B-C7) in the treatment of refractory severe acute GVHD. Blood 1992; 79: 3362–3368
- Keener Y., Singer A., Nagler A., Slavin S., Fabian I. Ciprofloxacin enhances hematopoiesis and the antibacterial activity of peritoneal polymorphonuclears in lethally irradiated bone marrow transplanted mice. Exper. Hematol 1994; 22: 360–365